8-K: Arogo Capital Acquisition Corp. Faces Nasdaq Delisting, Plans OTCQB Listing
Delisting Notice
Arogo Capital Acquisition Corp. has received notice of delisting from Nasdaq due to non-compliance with listing requirements and plans to move to the OTCQB market.
Summary
- Arogo Capital Acquisition Corp. received a delisting notice from Nasdaq due to not meeting minimum listing requirements.
- The company failed to maintain a market value of listed securities of at least $50 million, a minimum of 1,100,000 publicly held shares, and at least 400 total holders.
- The company's request to continue its listing on Nasdaq was rejected by the Panel.
- Trading of the company's securities on Nasdaq will be suspended at the open of trading on September 17, 2024.
- The company intends to apply for listing on the OTCQB Market and expects to begin trading on the OTC Pink Market on September 17, 2024, under the same symbols.
- The company plans to continue making all required SEC filings and maintain compliance with Nasdaq corporate governance requirements.
- Arogo is also working on a proposed business combination and will file a proxy statement/prospectus with the SEC.
Sentiment
Score: 3
Explanation: The sentiment is negative due to the delisting from Nasdaq, which is a significant setback. While the company is trying to move to the OTC market, this is generally seen as a less desirable outcome.
Positives
- The company intends to continue making all required SEC filings, ensuring transparency.
- Arogo plans to maintain compliance with Nasdaq corporate governance requirements despite the delisting.
- The company is actively pursuing a listing on the OTCQB market.
- The company is working on a proposed business combination, which could provide future value.
Negatives
- The company has been delisted from Nasdaq due to failing to meet listing requirements.
- The company's securities will be suspended from trading on Nasdaq.
- There is no guarantee that the company's securities will be approved for trading on the OTCQB market.
- The company has failed to maintain a market value of at least $50 million.
Risks
- There is a risk that the company's securities may not be approved for trading on the OTCQB market.
- The company's stock price may be negatively impacted by the delisting from Nasdaq.
- The business combination may not be completed successfully.
- The company's ability to raise capital may be affected by the delisting.
Future Outlook
The company intends to apply for listing on the OTCQB Market and expects to begin trading on the OTC Pink Market on September 17, 2024. They are also working on a proposed business combination and will file a proxy statement/prospectus with the SEC.
Management Comments
- The company described its ongoing efforts to regain compliance with the Nasdaq Listing Requirements during the hearing.
- The company notified the Panel that it intended to apply for listing of its securities on OTCQB.
- The company intends to continue to make all required SEC filings and maintain compliance with Nasdaq corporate governance requirements.
Industry Context
This announcement reflects the challenges faced by some special purpose acquisition companies (SPACs) in maintaining listing compliance, particularly in a volatile market. The move to the OTC market is not uncommon for companies facing delisting from major exchanges.
Comparison to Industry Standards
- Many SPACs have struggled to maintain listing requirements, especially those that have not completed a business combination within the required timeframe.
- Companies like Canoo and Lordstown Motors have also faced delisting threats due to similar issues.
- The move to the OTC market is a common path for companies that fail to meet Nasdaq or NYSE listing standards, but it often results in lower trading volumes and reduced investor interest.
Stakeholder Impact
- Shareholders will likely experience a negative impact due to the delisting from Nasdaq.
- The company's employees may face uncertainty due to the change in listing status.
- The company's creditors may be concerned about the company's financial stability.
Next Steps
- The company will apply for listing on the OTCQB Market.
- The company expects to begin trading on the OTC Pink Market on September 17, 2024.
- The company will file a registration statement on Form F-4, including a proxy statement/prospectus, with the SEC for the proposed business combination.
Key Dates
| Date | Description |
|---|---|
| 2024-01-10 | Arogo received the first notification letter from Nasdaq regarding non-compliance with listing requirements. |
| 2024-03-12 | Arogo disclosed the first notification letter in a Form 8-K filing. |
| 2024-05-10 | Arogo filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2023. |
| 2024-07-31 | Arogo received another notification letter from Nasdaq regarding non-compliance with listing requirements. |
| 2024-08-06 | Arogo disclosed the second notification letter in a Form 8-K filing and paid the fee for a hearing. |
| 2024-08-12 | Arogo received another notification letter from Nasdaq regarding non-compliance with listing requirements. |
| 2024-08-19 | Arogo disclosed the third notification letter in a Form 8-K filing. |
| 2024-08-21 | Arogo amended the Form 8-K filing from August 19, 2024. |
| 2024-09-12 | Arogo had a hearing with the Nasdaq Panel. |
| 2024-09-13 | Arogo received the Nasdaq Delisting Notice. |
| 2024-09-17 | Trading of Arogo's securities on Nasdaq will be suspended, and trading on the OTC Pink Market is expected to begin. |
Keywords
Delisting, Nasdaq, OTCQB, OTC Pink Market, Listing Requirements, Business Combination, SEC Filings, Arogo Capital Acquisition Corp, AOGO, AOGOU, AOGOW
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.